NIDA INFOFAX AND MISCELLANEOUS COMMUNICATIONS MATERIAL

Release Date:  May 27, 1999

RFP AVAILABLE: N01DA-9-2064

P.T.

National Institute on Drug Abuse

The National Institute on Drug Abuse (NIDA) is soliciting proposals from 
qualified organizations having in-house capability to provide technical support 
for enhancing and increasing the availability and accessibility of NIDA 
information to a broad variety of publics.  Specifically, to:  (1) further 
publicize, oversee and refine operation of NIDA�s already successful NIDA 
INFOFAX system; (2) provide writing work, particularly press and/or publicity-
related, as needed; (3) provide Spanish audio and written translations, as 
needed; (4) provide clear-cut marketing plans for a variety of projects, to 
establish continuous monthly exposure of NIDA products to the public; (5) 
provide unique and striking graphics to accompany the marketing and/or products 
themselves; (6) conduct focus group testing as needed for products; (7) oversee 
marketing activities, including coordinating placement of products; and (8) 
provide regular evaluations for effectiveness of the products and of the impact 
of dissemination and marketing.

Organizations submitting proposals should demonstrate extensive experience in 
public health communications and a high understanding of the capabilities and 
services from, and products available through, the National Institute on Drug 
Abuse and other NIH institutes, as well as state-of-the-art fax-on-demand 
systems.  Specifically, organizations submitting should be capable of providing 
whatever staff and effort are necessary to:  (1) demonstrate extensive 
experience in public health communications; (2) create, through computer 
graphics, a readily identifiable design for this NIDA service; (3) write and 
edit, as well as translate into Spanish, scientific material in language easily 
understood by a broad variety of publics; (4) demonstrate experience in 
developing marketing strategies and producing marketing and advertising 
materials; and (5) be capable of ensuring operability of the fax-on-demand 
system at 99% efficiency.


RFP No. N01DA-9-2064 will be available electronically on or about June 17, 
1999, and may be accessed through the Internet at the following address: (URL: 
http://www.nida.nih.gov/RFP/RFPList.html )

Please note that the RFP for this acquisition will be streamlined to include 
only the Work Statement, Deliverables and Reporting Requirements, Special 
Requirements and Mandatory Qualifications, Technical Evaluation Criteria, and 
other necessary Proposal Preparation Instructions.  All information required 
for submission of an offer will be contained in or accessible through the 
electronic RFP package.  

Response to the RFP will be due on or about July 16, 1999.  This requirement 
will be a total small business set-aside.  Any responsible offeror may submit a 
proposal which will be considered by the Government. 

Point of Contact: 	Michelle L. Scala, Contract Specialist
National Institute on Drug Abuse, NIH
Contracts Management Branch, OPRM
6001 Executive Boulevard
Room 3105, MSC 9543
Bethesda, Maryland 20892-9543
Electronic Mail Address: ms35n@nih.gov
Telephone: (301) 443-6677
Fax: (301) 443-7595

Return to Volume Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.